Nice recap calstang. Given that we expected the trial to be continued, yesterday was about as good a day as we could have had, and I think its served to support the share price.

Ill be honest, I was expecting there to be more of a drop... I think many investors are trying to decide how long they can wait to re-enter.

Its looking like end of January/February for the next major catalyst, but I suspect as enrollment picks back up and we approach enrollment of 293, there will be more pressure to get back in, and the share price will reflect that.